The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease.
about
Cholesterol Depletion from a Ceramide/Cholesterol Mixed Monolayer: A Brewster Angle Microscope Study.In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts.Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysisEvidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.Host plasma low density lipoprotein particles as an essential source of lipids for the bloodstream forms of Trypanosoma brucei.
P2860
The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The in situ degradation of cer ...... ly impaired in Farber disease.
@en
type
label
The in situ degradation of cer ...... ly impaired in Farber disease.
@en
prefLabel
The in situ degradation of cer ...... ly impaired in Farber disease.
@en
P2093
P2860
P1433
P1476
The in situ degradation of cer ...... ly impaired in Farber disease.
@en
P2093
P2860
P304
P356
10.1016/0014-5793(93)80243-N
P407
P577
1993-08-01T00:00:00Z